<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34992096</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-7766</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Practical neurology</Title><ISOAbbreviation>Pract Neurol</ISOAbbreviation></Journal><ArticleTitle>Diagnosing ALS: the Gold Coast criteria and the role of EMG.</ArticleTitle><Pagination><StartPage>176</StartPage><EndPage>178</EndPage><MedlinePgn>176-178</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/practneurol-2021-003256</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0003-0267-3180</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford Medical Sciences Division, Oxford OX3 9DU, UK martin.turner@ndcn.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>UK MND Clinical Studies Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TURNER/OCT18/989-797</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pract Neurol</MedlineTA><NlmUniqueID>101130961</NlmUniqueID><ISSNLinking>1474-7758</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">EMG</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Al-Chalabi</LastName><ForeName>Ammar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baker</LastName><ForeName>Idris</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barritt</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chandran</LastName><ForeName>Siddharthan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chhetri</LastName><ForeName>Suresh Kumar</ForeName><Initials>SK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davenport</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ealing</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gorrie</LastName><ForeName>George H</ForeName><Initials>GH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hamdalla</LastName><ForeName>Hisham</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oliver Hanemann</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lambert</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morrison</LastName><ForeName>Karen E</ForeName><Initials>KE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orrell</LastName><ForeName>Richard W</ForeName><Initials>RW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pal</LastName><ForeName>Suvankar</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Radunovic</LastName><ForeName>Aleksander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rafiq</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Talbot</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Young</LastName><ForeName>Carolyn A</ForeName><Initials>CA</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34992096</ArticleId><ArticleId IdType="pmc">PMC9120398</ArticleId><ArticleId IdType="doi">10.1136/practneurol-2021-003256</ArticleId><ArticleId IdType="pii">practneurol-2021-003256</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shefner JM, Al-Chalabi A, Baker MR, et al. . A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 2020;131:1975&#x2013;8. 10.1016/j.clinph.2020.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Ferguson TA, Cummings C, et al. . Gold Coast diagnostic criteria: implications for ALS diagnosis and clinical trial enrollment. Muscle Nerve 2021;64:532&#x2013;7. 10.1002/mus.27392</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27392</ArticleId><ArticleId IdType="pubmed">34378224</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen D, Yang X, Wang Y, et al. . The Gold Coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population. Transl Neurodegener 2021;10:28. 10.1186/s40035-021-00253-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00253-2</ArticleId><ArticleId IdType="pmc">PMC8351337</ArticleId><ArticleId IdType="pubmed">34372918</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugdahl K, Camdessanch&#xe9; J-P, Cengiz B, et al. . Gold Coast diagnostic criteria increase sensitivity in amyotrophic lateral sclerosis. Clin Neurophysiol 2021. 10.1016/j.clinph.2021.08.014. [Epub ahead of print: 08 Sep 2021].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.08.014</ArticleId><ArticleId IdType="pubmed">34544646</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannaford A, Pavey N, van den Bos M, et al. . Diagnostic utility of gold Coast criteria in amyotrophic lateral sclerosis. Ann Neurol 2021;89:979&#x2013;86. 10.1002/ana.26045</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26045</ArticleId><ArticleId IdType="pubmed">33565111</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR. The reunification of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2019;90:122&#x2013;3. 10.1136/jnnp-2018-319470</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319470</ArticleId><ArticleId IdType="pubmed">30297521</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince PG, Evans J, Knopp M, et al. . Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003;60:1252&#x2013;8. 10.1212/01.WNL.0000058901.75728.4E</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000058901.75728.4E</ArticleId><ArticleId IdType="pubmed">12707426</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbohm A, M&#xfc;ller H-P, H&#xfc;bers A, et al. . Corticoefferent pathways in pure lower motor neuron disease: a diffusion tensor imaging study. J Neurol 2016;263:2430&#x2013;7. 10.1007/s00415-016-8281-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8281-2</ArticleId><ArticleId IdType="pubmed">27624123</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Talbot K. Primary lateral sclerosis: diagnosis and management. Pract Neurol 2020;20:262&#x2013;9. 10.1136/practneurol-2019-002300</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/practneurol-2019-002300</ArticleId><ArticleId IdType="pubmed">32217663</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor BJ, Codd MB, Corr B, et al. . Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie house diagnostic criteria. Arch Neurol 2000;57:1171&#x2013;6. 10.1001/archneur.57.8.1171</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.57.8.1171</ArticleId><ArticleId IdType="pubmed">10927797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>